Literature DB >> 3071765

High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: preliminary data of a phase-II study.

G A Nagel1, W Rauschning, A Ammon, J H Beyer, D Emrich, W Holtkamp, M Kneba, H Luig, N Marschner, C Unger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3071765     DOI： 10.1159/000216560

Source DB:  PubMed          Journal:  Onkologie        ISSN： 0378-584X


× No keyword cloud information.
  1 in total

1.  Palliative chemo-radiotherapy with ifosfamide and epirubicin as first-line treatment for high-risk metastatic breast cancer. Results of a prospective multicenter trial.

Authors:  O F Lange; W Scheef; K D Haase; M Heckmann; R Leyendecker; G Urban; G Zegners
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.